// App-Quantinova.ai

5167 : Identification and validation of a novel immuno-oncology target and selection of a therapeutic antibody candidate with a pharmacologically beneficial activity profile

Researchers

Presenter

  • Arnima Bisht

Principal Investigators

  • Angelo Kaplan

  • Livija Deban

  • Chander Sekhar Peddaboina

  • Murray Cox

  • Lindsey Hudson

  • James Ackroyd

  • Nickolas Attanasio

  • San Lin Lou

  • Jason Allen

  • Martin Barnes

  • Robert Boyd

  • Eugene Zhukovsky

  • Abderrahim Fandi

  • Christian Rohlff

Medical Centers

  • Oxford BioTherapeutics Inc, San Jose, CA

  • PsiOxus Therapeutics Ltd., Abingdon, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

  • Programmed cell death protein 1

  • Cytotoxic T-lymphocyte-associated protein 4

  • tumor-infiltrating lymphocytes

  • Interferon

Drug/Treatment

  • Interferon Gamma

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved